Expanded criteria for hepatocellular carcinoma: Down-staging with a view to liver transplantation - Yes

被引:31
|
作者
Yao, Francis Y. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
hepatocellular carcinoma; orthotopic liver transplantation; Milan criteria; down-staging; University of California San Francisco criteria;
D O I
10.1055/s-2006-947295
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In patients with hepatocellular carcinoma (HCC) exceeding conventional Milan criteria (one lesion <= 5 cm or two or three lesions <= 3 cm) for orthotopic liver transplantation (OLT), down-staging of the tumor before OLT presents an unique and intriguing perspective on tumor biology and expanded criteria for OLT. According to the University of California, San Francisco protocol, the eligibility criteria for down-staging included one lesion <= 8 cm, two or three lesions each <= 5 cm with total tumor diameter <= 8 cm, or four or five lesions each <= 3 cm with total tumor diameter <= 8 cm. In the majority of these patients, successful down-staging using well-defined endpoints could be achieved prior to OLT, without resulting in post-transplantation HCC recurrence. The promise of down-staging warrants consideration of a unified policy granting patients with HCC that has been successfully down-staged the same priority listing for OLT as those meeting conventional criteria.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 50 条
  • [21] Successful liver transplantation for hepatocellular carcinoma following down-staging using sorafenib single therapy
    Borentain, Patrick
    Gregoire, Emilie
    Louis, Guillaume
    Gerolami, Rene
    LIVER INTERNATIONAL, 2016, 36 (09) : 1393 - 1393
  • [22] Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation
    Shi, Xian-Jie
    Jin, Xin
    Wang, Mao-Qiang
    Wei, Li-Xin
    Ye, Hui-Yi
    Liang, Yu-Rong
    Luo, Ying
    Dong, Jia-Hong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (02) : 143 - 150
  • [23] Expanded criteria for hepatocellular carcinoma and liver transplantation
    Moray, G.
    Karakayali, F.
    Yilmaz, U.
    Ozcay, F.
    Bilezikci, B.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) : 1171 - 1174
  • [24] Expanded criteria for hepatocellular carcinoma and liver transplantation
    Haberal, Mehmet
    Emiroglu, Remzi
    Karakayali, Hamdi
    Moray, Gokhan
    Yilmaz, Ugur
    Ozcay, Figen
    Bilezikci, Banu
    Arslan, Gulnaz
    INTERNATIONAL SURGERY, 2007, 92 (02) : 110 - 115
  • [25] Continuing Success with Down-Staging of Hepatocellular Carcinoma
    不详
    LIVER TRANSPLANTATION, 2008, 14 (12) : 1810 - 1812
  • [26] Down-Staging of Hepatocellular Carcinoma Before Liver Transplantation: Should We Change Our Clinical Practice?
    Ravaioli, Matteo
    Grazi, Gian Luca
    Cescon, Matteo
    Ercolani, Giorgio
    Pinna, Antonio Daniele
    Piscaglia, Fabio
    Trevisani, Franco
    ANNALS OF SURGERY, 2009, 250 (02) : 348 - 348
  • [27] Reassessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand With Tumor Down-Staging?
    Yao, Francis Y.
    Fidelman, Nicholas
    HEPATOLOGY, 2016, 63 (03) : 1014 - 1025
  • [28] Follow-up analysis of a prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation
    Yao, Francis Y.
    Hirose, Ryutaro
    Kerlan, Robert K.
    Davern, Timothy J.
    Merriman, Raphael
    Feng, Sandy
    Peters, Marion
    Freise, Chris
    Ascher, Nancy L.
    Bass, Nathan M.
    Roberts, John P.
    HEPATOLOGY, 2006, 44 (04) : 195A - 195A
  • [29] Survival Differences between Milan Criteria after Down-staging and De novo Milan in Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Lee, Sung-Gyu
    Hwang, Shin
    Kim, Ki-Hun
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Park, Gil-Chun
    Park, Yo-Han
    Park, Hyung-Woo
    Jung, Bo-Hyun
    Kang, Sung-Hwa
    HEPATO-GASTROENTEROLOGY, 2014, 61 (129) : 187 - 191
  • [30] Outcomes of hepatocellular carcinoma beyond the UCSF criteria after upfront living donor liver transplant and down-staging
    Wong, T.
    Mehta, N.
    Chan, W. O.
    Yao, F.
    Lo, C. M.
    TRANSPLANTATION, 2022, 106 (8S) : 59 - 59